Evidence map›Paper›PMID 16594641›Full record

ReviewThe AAPS journal2006

Neuronal nicotinic acetylcholine receptor expression and function on nonneuronal cells.

Lorise C Gahring, Scott W Rogers

Open access · bronzeAbstract readReview
In one paragraph

Review in The AAPS journal, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 149 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Translational Research in Nicotine Addiction.Cold Spring Harbor perspectives in medicine · 2021
    Review
  5. Article
  6. Review
  7. Inhaled aerosolized nicotine suppresses the lung eosinophilic response to house dust mite allergen.American journal of physiology. Lung cellular and molecular physiology · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Biliary epithelium: A neuroendocrine compartment in cholestatic liver disease.Clinics and research in hepatology and gastroenterology · 2018
    Review
  13. Acetylcholine nicotinic receptor subtypes in chromaffin cells.Pflugers Archiv : European journal of physiology · 2018
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Lorise C GahringGeriatric Research Education and Clinical Center, Salt Lake City VAMC, Salt Lake City, Utah 84132, USA. Lorise.Gahring@hsc.utah.edu
Scott W Rogers
Geriatric Research Education and Clinical Center · USVA Salt Lake City Healthcare System · US

Funding

Nicotine Abuse /Smoking-Related Disease SusceptibilityP01HL072903 · NHLBI · UNIVERSITY OF UTAH · PI HOIDAL, JOHN R · 2002 to 2006
$11.1M
Cholinergic Modulation of Inflammatory CNS CytokinesR01DA015148 · NIDA · UNIVERSITY OF UTAH · PI GAHRING, LORISE C · 2003 to 2006
$1.2M
Nicotine Modulation of Caspases in Non-Neuronal CellsR21DA018930 · NIDA · UNIVERSITY OF UTAH · PI GAHRING, LORISE C · 2005 to 2006
$295k
NHLBI NIH HHS P01-HL72903NIDA NIH HHS DA015148NIDA NIH HHS DA018930
6 · The paper itself

Abstract

Of the thousands of proven carcinogens and toxic agents contained within a cigarette, nicotine, while being the addictive agent, is often viewed as the least harmful of these compounds. Nicotine is a lipophilic molecule whose effects on neuronal nicotinic acetylcholine receptors (nAChR) have been primarily focused on its physiologic impact within the confines of the brain and peripheral nervous system. However, recently, many studies have found neuronal nAChRs to be expressed on many different nonneuronal cell types throughout the body, where increasing evidence suggests they have important roles in determining the consequences of nicotine use on multiple organs systems and diseases as diverse as ulcerative colitis, chronic pulmonary obstructive disease, and diabetes, as well as the neurologic disorders of Parkinson's and Alzheimer's disease. This review highlights current evidence for the expression of peripheral nAChRs in cells other than neurons and how they participate in fundamental processes, such as inflammation. Understanding these processes may offer novel therapeutic strategies to approach inflammatory diseases, as well as precautions in the design of interventional drugs.

Indexed as

AnimalsCholinergic AgentsGene Expression RegulationHumansNeuronsReceptors, NicotinicCholinergic AgentsReceptors, Nicotinic

Identifiers

PMID16594641
PMCPMC2750958
OpenAlexW1993373360

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.